Nkarta to Participate at Upcoming Investor Conferences
07 11월 2023 - 10:02PM
Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing
engineered natural killer (NK) cell therapies, today announced its
participation at two upcoming investor conferences:
Stifel
Healthcare ConferenceNovember 14, 202310:55 a.m. ET –
fireside chat
Evercore ISI HealthCONx
ConferenceNovember 28, 202312:30 p.m. ET – fireside
chat
A simultaneous webcast of each event will be available on the
Investors section of Nkarta’s website, www.nkartatx.com, and a
replay will be archived on the website for approximately 90
days.
About NkartaNkarta is a clinical-stage
biotechnology company advancing the development of allogeneic,
off-the-shelf natural killer (NK) cell therapies. By combining its
cell expansion and cryopreservation platform with proprietary cell
engineering technologies and CRISPR-based genome engineering
capabilities, Nkarta is building a pipeline of future cell
therapies engineered for deep therapeutic activity and intended for
broad access in the outpatient treatment setting. For more
information, please visit the company’s website at
www.nkartatx.com.
Nkarta Media/Investor Contact:Greg MannNkarta,
Inc.gmann@nkartatx.com
Nkarta (NASDAQ:NKTX)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Nkarta (NASDAQ:NKTX)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024